Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexinidazole Dosing Regimens for Chronic Indeterminate Chagas Disease
NCT03587766Phase 2Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Nov 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fexinidazole in Chagas disease, sponsored by Drugs for Neglected Diseases initiative. Started Nov 2017; status: completed.
02
Drugs
Fexinidazole
03
Conditions
Chagas disease
Beyond the preview
Go deeper on NCT03587766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03587766.